F13L (p.Phe13Leu) variant of CALM3 (Calmodulin-3)

F13L (p.Phe13Leu) in CALM3 (Calmodulin-3) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.61 / 1. The record also includes population frequency data and structural context.

F13L (p.Phe13Leu) variant details